BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33049119)

  • 1. Randomized pilot trial of ipratropium versus placebo in children with critical asthma.
    Murphy K; Mahmood N; Craven D; Gallagher J; Ross K; Speicher R; Rotta AT; Shein SL
    Pediatr Pulmonol; 2020 Dec; 55(12):3287-3292. PubMed ID: 33049119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation.
    Goggin N; Macarthur C; Parkin PC
    Arch Pediatr Adolesc Med; 2001 Dec; 155(12):1329-34. PubMed ID: 11732951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, double-blind, placebo-controlled trial of intravenous salbutamol and nebulized ipratropium bromide in early management of severe acute asthma in children presenting to an emergency department.
    Browne GJ; Trieu L; Van Asperen P
    Crit Care Med; 2002 Feb; 30(2):448-53. PubMed ID: 11889328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Nebulized Magnesium vs Placebo Added to Albuterol on Hospitalization Among Children With Refractory Acute Asthma Treated in the Emergency Department: A Randomized Clinical Trial.
    Schuh S; Sweeney J; Rumantir M; Coates AL; Willan AR; Stephens D; Atenafu EG; Finkelstein Y; Thompson G; Zemek R; Plint AC; Gravel J; Ducharme FM; Johnson DW; Black K; Curtis S; Beer D; Klassen TP; Nicksy D; Freedman SB;
    JAMA; 2020 Nov; 324(20):2038-2047. PubMed ID: 33231663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma.
    Craven D; Kercsmar CM; Myers TR; O'riordan MA; Golonka G; Moore S
    J Pediatr; 2001 Jan; 138(1):51-58. PubMed ID: 11148512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of frequent nebulized ipratropium bromide added to frequent high-dose albuterol therapy in severe childhood asthma.
    Schuh S; Johnson DW; Callahan S; Canny G; Levison H
    J Pediatr; 1995 Apr; 126(4):639-45. PubMed ID: 7699549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of nebulized ipratropium on the hospitalization rates of children with asthma.
    Qureshi F; Pestian J; Davis P; Zaritsky A
    N Engl J Med; 1998 Oct; 339(15):1030-5. PubMed ID: 9761804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ipratropium bromide added to asthma treatment in the pediatric emergency department.
    Zorc JJ; Pusic MV; Ogborn CJ; Lebet R; Duggan AK
    Pediatrics; 1999 Apr; 103(4 Pt 1):748-52. PubMed ID: 10103297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled trial of ipratropium bromide and frequent low doses of salbutamol in the management of mild and moderate acute pediatric asthma.
    Ducharme FM; Davis GM
    J Pediatr; 1998 Oct; 133(4):479-85. PubMed ID: 9787684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addition of ipratropium to nebulized albuterol in children with acute asthma presenting to a pediatric office.
    Kumaratne M; Gunawardane G
    Clin Pediatr (Phila); 2003 Mar; 42(2):127-32. PubMed ID: 12659385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison efficacy of randomized nebulized magnesium sulfate and ipratropium bromide/fenoterol in children with moderate to severe asthma exacerbation.
    Wongwaree S; Daengsuwan T
    Asian Pac J Allergy Immunol; 2022 Mar; 40(1):31-38. PubMed ID: 31421659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nebulized magnesium for moderate and severe pediatric asthma: A randomized trial.
    Alansari K; Ahmed W; Davidson BL; Alamri M; Zakaria I; Alrifaai M
    Pediatr Pulmonol; 2015 Dec; 50(12):1191-9. PubMed ID: 25652104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of ipratropium and albuterol vs albuterol alone for the treatment of acute asthma.
    Karpel JP; Schacter EN; Fanta C; Levey D; Spiro P; Aldrich T; Menjoge SS; Witek TJ
    Chest; 1996 Sep; 110(3):611-6. PubMed ID: 8797400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, clinical trial comparing the efficacy of continuous nebulized albuterol (15 mg) versus continuous nebulized albuterol (15 mg) plus ipratropium bromide (2 mg) for the treatment of acute asthma.
    Salo D; Tuel M; Lavery RF; Reischel U; Lebowitz J; Moore T
    J Emerg Med; 2006 Nov; 31(4):371-6. PubMed ID: 17046476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of intravenous terbutaline versus normal saline in pediatric patients on continuous high-dose nebulized albuterol for status asthmaticus.
    Bogie AL; Towne D; Luckett PM; Abramo TJ; Wiebe RA
    Pediatr Emerg Care; 2007 Jun; 23(6):355-61. PubMed ID: 17572517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized controlled trial of ipratropium bromide and salbutamol versus salbutamol alone in children with acute exacerbation of asthma.
    Chakraborti A; Lodha R; Pandey RM; Kabra SK
    Indian J Pediatr; 2006 Nov; 73(11):979-83. PubMed ID: 17127777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to nebulized salbutamol versus combination with ipratropium bromide in children with acute severe asthma.
    Memon BN; Parkash A; Ahmed Khan KM; Gowa MA; Bai C
    J Pak Med Assoc; 2016 Mar; 66(3):243-6. PubMed ID: 26968269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standard dose of inhaled albuterol significantly increases QT dispersion compared to low dose of albuterol plus ipratropium bromide therapy in moderate to severe acute asthma attacks in children.
    Coskun S; Yuksel H; Tikiz H; Danahaliloğlu S
    Pediatr Int; 2001 Dec; 43(6):631-6. PubMed ID: 11737740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of adding ipratropium bromide to salbutamol in the treatment of acute asthma: a pooled analysis of three trials.
    Lanes SF; Garrett JE; Wentworth CE; Fitzgerald JM; Karpel JP
    Chest; 1998 Aug; 114(2):365-72. PubMed ID: 9726716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease.
    Levin DC; Little KS; Laughlin KR; Galbraith JM; Gustman PM; Murphy D; Kram JA; Hardie G; Reuter C; Ostransky D; McFarland K; Petty TL; Silvers W; Rennard SI; Mueller M; Repsher LH; Zuwallack RL; Vale R
    Am J Med; 1996 Jan; 100(1A):40S-48S. PubMed ID: 8610716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.